Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.

NCT07413315 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT07413315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 13, 2024
Completion date
December 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring hemodialysis, rehabilitation program, sarcopenia